ReviewInternational journal of molecular sciences2020

Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of View.

Manuela Labbozzetta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.